Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1-3 clinical trials: a Children's Cancer and Leukaemia Group (CCLG) Study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples